SBRA - CIK 0001492298
The table below shows Sabra Health Care REIT, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $348.61M | $310.54M | $300.57M | $315.73M | $356.39M | $354.85M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$377.96M | -$109.00M | $103.13M | -$216.25M | -$336.20M | -$136.45M |
| Dividends paid | $289.50M | $280.15M | $277.45M | $277.16M | $262.92M | $278.30M |
Sabra Health Care REIT, Inc. reported operating cash flow of $348.61M for fiscal year 2025. That is up 12.3% from $310.54M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $175.93M (FY 2016) to $348.61M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $40.76M | -$181.56M | -$410.30M | -$161.71M | $30.14M | -$202.11M |